Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Virology Journal|December 22, 2022
Adaptive immune responses and cytokine immune profiles in humans following prime and boost vaccination with the SARS-CoV-2 CoronaVac vaccineChan Wang, Songhao Yang, Liangwei Duan, et al.
Molecular Cancer|August 5, 2023
Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 studyLinlin Zhang, Liuchun Wang, Jingya Wang, et al.
Journal of Experimental Botany|January 12, 2020
Shading of the mother plant during seed development promotes subsequent seed germination in soybeanFeng Chen, Wenguan Zhou, Han Yin, et al.
Gene|April 29, 2014
Glucose-regulated protein 78 may play a crucial role in promoting the pulmonary microvascular remodeling in a rat model of hepatopulmonary syndromeHuiying Zhang, Minli Lv, Zhongfu Zhao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 11, 2024
Ethyl Lactate Ameliorates Hepatic Steatosis and Acute-on-Chronic Liver Injury in Alcohol-Associated Liver Disease by Inducing Fibroblast Growth Factor 21Yang Jiang, Shuang Wei, Shiming Shen, et al.
Gene|December 17, 2013
Expression of the 78 kD glucose-regulated protein is induced by endoplasmic reticulum stress in the development of hepatopulmonary syndromeHuiying Zhang, Minli Lv, Jiantao Jia, et al.
Thoracic Cancer|May 17, 2022
Prevalence and management of pain in lung cancer patients in northern China: A multicenter cross-sectional studyBo Zhang, Xingya Li, Zhiyong Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2020
Routine-Dose and High-Dose Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 21-L858R Mutation: the Randomized, Phase II, INCREASE TrialXi Li, Li Zhang, Da Jiang, et al.
Chinese Medical Journal|May 25, 2025
Programmed death-ligand 1 tumor proportion score in predicting the safety and efficacy of PD-1/PD-L1 antibody-based therapy in patients with advanced non-small cell lung cancer: A retrospective, multicenter, observational studyYuequan Shi, Xiaoyan Liu, Anwen Liu, et al.
JMIR Cancer|June 5, 2024
Telehealth With Comprehensive Live-Fed Real-World Data as a Patient Care Platform for Lung Cancer: Implementation and Evaluation StudyDi Zheng, Yanhong Shang, Jian Ni, et al.
Pageof 12